BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 12093267)

  • 1. Summaries for patients. Using medication to prevent breast cancer: recommendations from the United States Preventive Services Task Force.
    Ann Intern Med; 2002 Jul; 137(1):I62. PubMed ID: 12093267
    [No Abstract]   [Full Text] [Related]  

  • 2. Chemoprevention of breast cancer: recommendations and rationale.
    U.S. Preventive Services Task Force
    Ann Intern Med; 2002 Jul; 137(1):56-8. PubMed ID: 12093249
    [No Abstract]   [Full Text] [Related]  

  • 3. Chemoprevention of breast cancer: a summary of the evidence for the U.S. Preventive Services Task Force.
    Kinsinger LS; Harris R; Woolf SH; Sox HC; Lohr KN
    Ann Intern Med; 2002 Jul; 137(1):59-69. PubMed ID: 12093250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Task force cautious about chemoprevention. Official guidelines are out about taking tamoxifen and raloxifene to prevent breast cancer. These drugs can help, but they aren't for everyone.
    Harv Womens Health Watch; 2002 Oct; 10(2):1-2. PubMed ID: 12393316
    [No Abstract]   [Full Text] [Related]  

  • 5. Medications for Primary Prevention of Breast Cancer.
    Shieh Y; Tice JA
    JAMA; 2020 Jul; 324(3):291-292. PubMed ID: 32692377
    [No Abstract]   [Full Text] [Related]  

  • 6. Chemoprevention or mastectomy for women at high risk of developing breast cancer.
    Sismondi P; D'Alonzo M; Pecchio S; Bounous VE; Robba E; Biglia N
    Maturitas; 2015 Nov; 82(3):271-3. PubMed ID: 26276104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemoprevention of breast cancer.
    Thomsen A; Kolesar JM
    Am J Health Syst Pharm; 2008 Dec; 65(23):2221-8. PubMed ID: 19020189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemoprevention of breast cancer.
    Zelnak AB; O'Regan RM
    Curr Probl Cancer; 2004; 28(4):201-17. PubMed ID: 15318323
    [No Abstract]   [Full Text] [Related]  

  • 9. Exemestane for primary prevention of breast cancer in postmenopausal women.
    Zhang Y; Simondsen K; Kolesar JM
    Am J Health Syst Pharm; 2012 Aug; 69(16):1384-8. PubMed ID: 22855103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The breast cancer chemoprevention debate.
    Schmidt C
    J Natl Cancer Inst; 2011 Nov; 103(22):1646-7. PubMed ID: 22025628
    [No Abstract]   [Full Text] [Related]  

  • 11. Chemoprevention of breast cancer: recommendations and rationale.
    Berg AO;
    Am J Nurs; 2003 May; 103(5):107, 109, 111, 113. PubMed ID: 12759615
    [No Abstract]   [Full Text] [Related]  

  • 12. Carcinoma in situ outcomes in National Surgical Adjuvant Breast and Bowel Project Breast Cancer Chemoprevention Trials.
    Vogel VG; Costantino JP; Wickerham DL; McCaskill-Stevens W; Clarfeld RB; Grant MD; Wolmark N
    J Natl Cancer Inst Monogr; 2010; 2010(41):181-6. PubMed ID: 20956826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breast cancer chemoprevention: A service in need of menopause specialist support.
    Marsden J
    Post Reprod Health; 2017 Mar; 23(1):15-21. PubMed ID: 28081658
    [No Abstract]   [Full Text] [Related]  

  • 14. Chemoprevention of breast cancer. A joint guideline from the Canadian Task Force on Preventive Health Care and the Canadian Breast Cancer Initiative's Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer.
    Levine M; Moutquin JM; Walton R; Feightner J;
    CMAJ; 2001 Jun; 164(12):1681-90. PubMed ID: 11450210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. STAR: first-year recruitment efforts set brisk pace for future.
    CA Cancer J Clin; 2000; 50(5):271-2. PubMed ID: 11075236
    [No Abstract]   [Full Text] [Related]  

  • 16. Preventive therapy for breast cancer: a consensus statement.
    Cuzick J; DeCensi A; Arun B; Brown PH; Castiglione M; Dunn B; Forbes JF; Glaus A; Howell A; von Minckwitz G; Vogel V; Zwierzina H
    Lancet Oncol; 2011 May; 12(5):496-503. PubMed ID: 21441069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breast cancer chemoprevention: current clinical practice and future direction.
    Bevers TB
    Biomed Pharmacother; 2001 Nov; 55(9-10):559-64. PubMed ID: 11769967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Raloxifene in breast cancer prevention.
    Gennari L; Merlotti D; Paola VD; Nuti R
    Expert Opin Drug Saf; 2008 May; 7(3):259-70. PubMed ID: 18462184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medication Use for the Risk Reduction of Primary Breast Cancer in Women: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
    Nelson HD; Fu R; Zakher B; Pappas M; McDonagh M
    JAMA; 2019 Sep; 322(9):868-886. PubMed ID: 31479143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary prevention of breast cancer: new approaches.
    Cummings SR
    Maturitas; 2007 May; 57(1):39-41. PubMed ID: 17391879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.